Application status of endoscopic anti-reflux mucosal interventions in the treatment of gastroesophageal reflux disease

Table 4 Concise inclusion criteria for anti-reflux mucosal ablation and peroral endoscopic cardial constriction in gastroesophageal reflux disease patients

Ref.	Year	Intervention	Inclusion criteria
			GERD diagnosis	Hiatal hernia	Hill score	Los Angeles’s grade	Barrett’s esophagus
Inoue et al[19]	2020	ARMA	Refractory GERD	≤ 3 cm	≤ 3	NA	NA
Hernández Mondragón et al[20]	2020	ARAT	Refractory GERD	Without	≤ 3	NA	Excluded
Chou et al[22]	2023	ARMA	PPI-depended GERD	≤ 3 cm	2-3	NA	NA
Shimamura et al[23]	2024	ARMA	Refractory/PPI-depended GERD	≤ 3 cm	NA	NA	NA
Klimczak et al[24]	2023	ARMA	Refractory GERD	NA	NA	NA	NA
Li et al[25]	2017	PECC	GERD	NA	NA	NA	NA
Liu et al[26]	2020	C-BLART	Refractory GERD	≤ 2 cm	NA	A-C	Excluded
Seleem et al[27]	2018	EBL	Refractory GERD	≤ 2 cm	NA	A-B	NA
Li et al[28]	2021	PECC-b	GERD	≤ 2 cm	NA	NA	NA
Jiang et al[29]	2022	PECC-b	Refractory/PPI-depended GERD	≤ 2 cm	NA	NA	Excluded
Deshmukh et al[30]	2022	ARBM	Refractory GERD	≤ 2 cm	NA	NA	NA
Hu et al[34]	2018	PECC	GERD	≤ 3 cm	NA	NA	Excluded
Wang et al[39]	2020	PECC	Refractory/PPI-depended GERD	≤ 3 cm	NA	NA	Excluded

ARMA: Anti-reflux mucosal ablation; ARAT: Anti-reflux ablation therapy; PECC: Peroral endoscopic cardial constriction; EBL: Endoscopic band ligation; C-BLART: Clip band ligation anti-reflux therapy; PECC-b: Peroral endoscopic cardial constriction with band ligation; ARBM: Anti-reflux band mucosectomy; GERD: Gastroesophageal reflux disease; PPI: Proton pump inhibitor; NA: Not available.